Literature DB >> 16101867

Serum interleukin-8 as a serologic marker of activity in Behçet's disease.

Güneş Gür-Toy1, Nurdan Lenk, Basak Yalcin, Sabahat Aksaray, Nuran Alli.   

Abstract

BACKGROUND: Immune dysregulation has been shown to be one of the major aspects of the yet unknown pathogenesis of Behçet's disease. Interleukin-8 (IL-8), a major chemokine with pivotal effects concerning leukocytes and endothelial cells, has been found to be elevated in patients with Behçet's disease. AIM: To evaluate the significance of elevated levels of IL-8 with respect to the activity of Behçet's disease.
METHODS: Sixty-seven consecutive patients with Behçet's disease (37 males, 30 females; 32.5 +/- 9.3 years) were enrolled in our study. The number of active clinical manifestations at the time of serum sampling was recorded. The degree of association between disease activity and IL-8, C-reactive protein, and erythrocyte sedimentation rate was assessed.
RESULTS: Serum levels of IL-8 increased as the number of clinically involved organs increased (P < 0.05). C-reactive protein and the erythrocyte sedimentation rate showed no correlation with disease activity.
CONCLUSIONS: Our study confirms that the IL-8 level is a more sensitive marker of disease activity than the erythrocyte sedimentation rate and C-reactive protein. It may be assumed that IL-8 plays an important role in the pathophysiology of Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101867     DOI: 10.1111/j.1365-4632.2004.02184.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  14 in total

1.  Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's disease.

Authors:  Sho Ueda; Mitsuteru Akahoshi; Atsunobu Takeda; Yasushi Inoue; Aya Omoto; Masahiro Ayano; Yasutaka Kimoto; Hiroki Mitoma; Yojiro Arinobu; Hiroaki Niiro; Hiroshi Tsukamoto; Takahiko Horiuchi; Shin-Ichi Hikita; Takako Fukuhara; Tatsuro Ishibashi; Koh-Hei Sonoda; Koichi Akashi
Journal:  Eur J Rheumatol       Date:  2018-03

Review 2.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

3.  Serum Cytokine Levels in Behçet's Disease.

Authors:  Zeynep Meltem Akkurt; Mehtap Bozkurt; Derya Uçmak; Hatice Yüksel; Haydar Uçak; Bilal Sula; Zeynep Gürsel Özkurt; Mehmet Yildiz; Dicle Akdeniz; Mustafa Arica
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

4.  [Comments on the pathogenesis of Behçet's disease. A key to understanding new therapies?].

Authors:  U Pleyer; D Hazirolan; N Stübiger
Journal:  Ophthalmologe       Date:  2012-06       Impact factor: 1.059

5.  Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population.

Authors:  Hongxia Dan; Wenzhao Liu; Yu Zhou; Jiayi Wang; Qianming Chen; Xin Zeng
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

6.  Successful treatment for sympathetic storms in a patient with neuro-Behçet's disease.

Authors:  Takahisa Gono; Megumi Murata; Yasushi Kawaguchi; Daisuke Wakasugi; Makoto Soejima; Hisashi Yamanaka; Masako Hara
Journal:  Clin Rheumatol       Date:  2008-12-20       Impact factor: 2.980

7.  Adamantiades-Behcet disease (ABD) in northern Greece patients: experience from a single center.

Authors:  P Boura; K Tselios; P Skendros; S Kamali; A Sarantopoulos; M Raptopoulou-Gigi
Journal:  Hippokratia       Date:  2007-10       Impact factor: 0.471

8.  Peripheral neuropathy in Behçet disease: an electroneurophysiological study.

Authors:  Lale Akbulut; Gunes Gur; Hatice Bodur; Nuran Alli; Pinar Borman
Journal:  Clin Rheumatol       Date:  2006-12-06       Impact factor: 3.650

9.  Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Behçet's Disease and Its Association with Disease Activity: A Pilot Study.

Authors:  Eun Chun Han; Sung Bin Cho; Keun Jae Ahn; Sang Ho Oh; Jihyun Kim; Dong Soo Kim; Kwang Hoon Lee; Dongsik Bang
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

10.  Behçet's: A Disease or a Syndrome? Answer from an Expression Profiling Study.

Authors:  Ali Kemal Oğuz; Seda Taşır Yılmaz; Çağdaş Şahap Oygür; Tuba Çandar; Irmak Sayın; Sibel Serin Kılıçoğlu; İhsan Ergün; Aşkın Ateş; Hilal Özdağ; Nejat Akar
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.